GLOBAL SACRAL NERVE STIMULATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Sacral nerve stimulation (SNS) is a minimally invasive procedure that involves placing a small medical device called an implantable neurostimulator to treat bladder, bowel, and pelvic floor disorders.

There are two types of sacral nerve stimulation systems - tined lead and paddle lead systems. Tined lead systems involve the insertion of a thin wire with tiny electrodes at the tip, called a lead, through the skin into the S3 sacral foramen area under imaging guidance. The lead is then attached to an internal pulse generator which is implanted in the lower butt area. Paddle lead systems involve surgically placing a lead with a flat, soft paddle at its tip which sits directly on the sacral nerve.

Both systems work by sending mild electrical pulses to the sacral nerves that control bowel and bladder function. This disrupts the abnormal signals causing symptoms and restores normal function. Sacral nerve stimulation has shown significant success in improving symptoms of overactive bladder, fecal incontinence, and chronic pelvic pain. Some advantages include being minimally invasive, with a adjustable therapy that can be turned on or off, byproviding improvements within days of being turned on. However, the implants do require permanent surgical placement and eventual battery replacement surgery. There is also a chance of leads moving out of optimal position long-term.

 Market Dynamics:

Global sacral nerve stimulation market is mainly driven by the increasing prevalence of chronic devices. For instance, according to the data published by the National Center for Biotechnology Information (NCBI) in December 2018, the global chronic pain prevalence survey found that 19.3% Indian adult population suffers from cerebral palsy.

Key features of the study:

• This report provides in-depth analysis of the global sacral nerve stimulation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global sacral nerve stimulation market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic plc., Boston Scientific Corporation, Nevro Corp, StimWave Technologies Inc., Axonics, Inc., Synapse Biomedical, Uroplasty, St. Jude Medical, Cogentix Medical, and Others
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global sacral nerve stimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dacral nerve stimulation market

Detailed Segmentation:

• Global Sacral Nerve Stimulation Market, By Product Type
  • Implantable SNS Devices
  • External SNS Devices
  • Accessories
• Global Sacral Nerve Stimulation Market, By Application
  • Urinary and Fecal Incontinence
  • Chronic Pain
  • Others
• Global Sacral Nerve Stimulation Market, By End User
  • Hospital
  • Clinics
  • Ambulatory Surgery Centers
• Global Sacral Nerve Stimulation Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Top Companies in the Global Sacral Nerve Stimulation Market:
  • Medtronic plc.
  • Boston Scientific Corporation
  • Nevro Corp
  • StimWave Technologies Inc.
  • Axonics, Inc.
  • Synapse Biomedical
  • Uroplasty
  • Jude Medical
  • Cogentix Medical
  • Others